Immunogenicity of Chitosan-Based Non-invasive Vaccine Strategy Against Mycobacterium tuberculosis
ImmunoAnalysis · 2023
DOI: 10.34172/ia.2023.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoAnalysis, 2023. Verfasst von Rasoul Hoseinpour und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
In spite of Bacillus Calmette-Guerin (BCG) vaccination, still tuberculosis caused by Mycobacterium tuberculosis remains a problematic impediment that requires perspective management. The aim of this study was to evaluate the immunogenicity of chitosan nanoparticles containing recombinant mycobacterial proteins and adjuvant in the Balb/C mice through a non-invasive nasal inhalation delivery route and measure the level of cytokines interferon gamma (IFN-γ), interleukin-4 (IL-4), and IL-17.
Methods
Thirty mice in five different groups were vaccinated through inhalation with compounds set in different combinations. Two weeks after the last nasal delivery, IFN-γ, IL-4, and IL-17 were measured in spleen cell culture supernatants.
Results
The IFN-γ and IL-17 concentrations were found to increase in the groups that received chitosan nanoparticles containing protein and adjuvant alone or as a BCG booster. Our study showed that the chitosan nanoparticle containing protein and adjuvant induced a Th1 response. However, the groups that first received BCG and then chitosan nanoparticles containing protein and adjuvant had the greatest Th1 response in terms of IFN-γ and IL-17 production in all the groups.
Conclusion
Our findings showed that the vaccine designed to be administered through the nasal mucosa well stimulates cellular immunity and enhances the BCG vaccine’s effectiveness.
Zitieren
APA
Hoseinpour, R., Hasani, A., Baradaran, B., Abdolalizadeh, J., Salehi, R., Hasani, A., Kafil, H. S., & Nabizadeh, E. (2023). Immunogenicity of Chitosan-Based Non-invasive Vaccine Strategy Against Mycobacterium tuberculosis. ImmunoAnalysis. https://doi.org/10.34172/ia.2023.02
Vancouver
Hoseinpour R, Hasani A, Baradaran B, Abdolalizadeh J, Salehi R, Hasani A, et al. Immunogenicity of Chitosan-Based Non-invasive Vaccine Strategy Against Mycobacterium tuberculosis. ImmunoAnalysis. 2023. doi:10.34172/ia.2023.02
BibTeX
@article{Hoseinpour2023,
author = {Hoseinpour, Rasoul and Hasani, Alka and Baradaran, Behzad and Abdolalizadeh, Jalal and Salehi, Roya and Hasani, Akbar and Kafil, Hossein Samadi and Nabizadeh, Edris},
title = {Immunogenicity of Chitosan-Based Non-invasive Vaccine Strategy Against Mycobacterium tuberculosis},
journal = {ImmunoAnalysis},
year = {2023},
doi = {10.34172/ia.2023.02}
}
EUVIMED